Tag: COAPT
ESC 2024: RESHAPE-HF2 results move conversation forward on effectiveness of TEER in functional MR
A strategy of mitral transcatheter edge-to-edge repair (TEER) plus medical therapy in patients with ...
EXPAND registry outcomes of new MitraClip devices in line with COAPT
Jörg Hausleiter (Munich, Germany) talks to Cardiovascular News about the one-year findings of ...
Early quality of life increases or benefits in COAPT translate to better long-term clinical outcomes
Early improvement in health status for patients in the COAPT trial who had transcatheter mitral ...
TCT 2019: COAPT finds MitraClip safety and efficacy is maintained at three years, and is cost-effective
The MitraClip device (Abbott) continues to demonstrate safety and efficacy at three years in pat...
ESC 2019: Two-year findings of MITRA-FR continue to show no prognosis benefit with MitraClip
At the European Society of Cardiology Congress (ESC 2019; 31 August–4 September, Paris, France),...
EuroPCR 2019: PCR issues statement on edge-to-edge repair in heart failure management with secondary MR
PCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) issued a s...
Reconciling the contrasting findings on MitraClip, and implications for the management of functional mitral regurgitation
Last year, the first two randomised controlled trials (RCT) looking at percutaneous edge-to-edge...
TCT 2018: Audience claps as COAPT shows MitraClip reduces HF hospitalisations
Delegates at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21-25 September, ...
